127 related articles for article (PubMed ID: 15339273)
1. Cytokeratin 18 interacts with the enteropathogenic Escherichia coli secreted protein F (EspF) and is redistributed after infection.
Viswanathan VK; Lukic S; Koutsouris A; Miao R; Muza MM; Hecht G
Cell Microbiol; 2004 Oct; 6(10):987-97. PubMed ID: 15339273
[TBL] [Abstract][Full Text] [Related]
2. Host protein interactions with enteropathogenic Escherichia coli (EPEC): 14-3-3tau binds Tir and has a role in EPEC-induced actin polymerization.
Patel A; Cummings N; Batchelor M; Hill PJ; Dubois T; Mellits KH; Frankel G; Connerton I
Cell Microbiol; 2006 Jan; 8(1):55-71. PubMed ID: 16367866
[TBL] [Abstract][Full Text] [Related]
3. Enteropathogenic Escherichia coli infection leads to appearance of aberrant tight junctions strands in the lateral membrane of intestinal epithelial cells.
Muza-Moons MM; Schneeberger EE; Hecht GA
Cell Microbiol; 2004 Aug; 6(8):783-93. PubMed ID: 15236645
[TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of EspF from enteropathogenic and enterohemorrhagic Escherichia coli in alteration of epithelial barrier function.
Viswanathan VK; Koutsouris A; Lukic S; Pilkinton M; Simonovic I; Simonovic M; Hecht G
Infect Immun; 2004 Jun; 72(6):3218-27. PubMed ID: 15155623
[TBL] [Abstract][Full Text] [Related]
5. Intestinal barrier dysfunction by enteropathogenic Escherichia coli is mediated by two effector molecules and a bacterial surface protein.
Dean P; Kenny B
Mol Microbiol; 2004 Nov; 54(3):665-75. PubMed ID: 15491358
[TBL] [Abstract][Full Text] [Related]
6. The enteropathogenic Escherichia coli EspF effector molecule inhibits PI-3 kinase-mediated uptake independently of mitochondrial targeting.
Quitard S; Dean P; Maresca M; Kenny B
Cell Microbiol; 2006 Jun; 8(6):972-81. PubMed ID: 16681838
[TBL] [Abstract][Full Text] [Related]
7. Translocation of enteropathogenic Escherichia coli across an in vitro M cell model is regulated by its type III secretion system.
Martinez-Argudo I; Sands C; Jepson MA
Cell Microbiol; 2007 Jun; 9(6):1538-46. PubMed ID: 17298392
[TBL] [Abstract][Full Text] [Related]
8. Balance of bacterial pro- and anti-inflammatory mediators dictates net effect of enteropathogenic Escherichia coli on intestinal epithelial cells.
Sharma R; Tesfay S; Tomson FL; Kanteti RP; Viswanathan VK; Hecht G
Am J Physiol Gastrointest Liver Physiol; 2006 Apr; 290(4):G685-94. PubMed ID: 16322091
[TBL] [Abstract][Full Text] [Related]
9. Alpha 1-antitrypsin binds to and interferes with functionality of EspB from atypical and typical enteropathogenic Escherichia coli strains.
Knappstein S; Ide T; Schmidt MA; Heusipp G
Infect Immun; 2004 Aug; 72(8):4344-50. PubMed ID: 15271889
[TBL] [Abstract][Full Text] [Related]
10. EspC translocation into epithelial cells by enteropathogenic Escherichia coli requires a concerted participation of type V and III secretion systems.
Vidal JE; Navarro-García F
Cell Microbiol; 2008 Oct; 10(10):1975-86. PubMed ID: 18547338
[TBL] [Abstract][Full Text] [Related]
11. Enteropathogenic Escherichia coli inhibits butyrate uptake in Caco-2 cells by altering the apical membrane MCT1 level.
Borthakur A; Gill RK; Hodges K; Ramaswamy K; Hecht G; Dudeja PK
Am J Physiol Gastrointest Liver Physiol; 2006 Jan; 290(1):G30-5. PubMed ID: 16150873
[TBL] [Abstract][Full Text] [Related]
12. The enteropathogenic Escherichia coli type III secretion system effector Map binds EBP50/NHERF1: implication for cell signalling and diarrhoea.
Simpson N; Shaw R; Crepin VF; Mundy R; FitzGerald AJ; Cummings N; Straatman-Iwanowska A; Connerton I; Knutton S; Frankel G
Mol Microbiol; 2006 Apr; 60(2):349-63. PubMed ID: 16573685
[TBL] [Abstract][Full Text] [Related]
13. EPEC effector EspF promotes Crumbs3 endocytosis and disrupts epithelial cell polarity.
Tapia R; Kralicek SE; Hecht GA
Cell Microbiol; 2017 Nov; 19(11):. PubMed ID: 28618099
[TBL] [Abstract][Full Text] [Related]
14. Enterohaemorrhagic and enteropathogenic Escherichia coli Tir proteins trigger a common Nck-independent actin assembly pathway.
Brady MJ; Campellone KG; Ghildiyal M; Leong JM
Cell Microbiol; 2007 Sep; 9(9):2242-53. PubMed ID: 17521329
[TBL] [Abstract][Full Text] [Related]
15. Paralysis and killing of Caenorhabditis elegans by enteropathogenic Escherichia coli requires the bacterial tryptophanase gene.
Anyanful A; Dolan-Livengood JM; Lewis T; Sheth S; Dezalia MN; Sherman MA; Kalman LV; Benian GM; Kalman D
Mol Microbiol; 2005 Aug; 57(4):988-1007. PubMed ID: 16091039
[TBL] [Abstract][Full Text] [Related]
16. The pathogenic E. coli type III effector EspZ interacts with host CD98 and facilitates host cell prosurvival signalling.
Shames SR; Deng W; Guttman JA; de Hoog CL; Li Y; Hardwidge PR; Sham HP; Vallance BA; Foster LJ; Finlay BB
Cell Microbiol; 2010 Sep; 12(9):1322-39. PubMed ID: 20374249
[TBL] [Abstract][Full Text] [Related]
17. Binding of intimin with Tir on the bacterial surface is prerequisite for the barrier disruption induced by enteropathogenic Escherichia coli.
Miyake M; Hanajima M; Matsuzawa T; Kobayashi C; Minami M; Abe A; Horiguchi Y
Biochem Biophys Res Commun; 2005 Nov; 337(3):922-7. PubMed ID: 16214109
[TBL] [Abstract][Full Text] [Related]
18. Enteropathogenic Escherichia coli EspF is targeted to mitochondria and is required to initiate the mitochondrial death pathway.
Nougayrède JP; Donnenberg MS
Cell Microbiol; 2004 Nov; 6(11):1097-111. PubMed ID: 15469437
[TBL] [Abstract][Full Text] [Related]
19. Invasion of enteropathogenic Escherichia coli into host cells through epithelial tight junctions.
Li Q; Zhang Q; Wang C; Li N; Li J
FEBS J; 2008 Dec; 275(23):6022-32. PubMed ID: 19016848
[TBL] [Abstract][Full Text] [Related]
20. Enterohaemorrhagic Escherichia coli Tir requires a C-terminal 12-residue peptide to initiate EspF-mediated actin assembly and harbours N-terminal sequences that influence pedestal length.
Campellone KG; Brady MJ; Alamares JG; Rowe DC; Skehan BM; Tipper DJ; Leong JM
Cell Microbiol; 2006 Sep; 8(9):1488-503. PubMed ID: 16922867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
